Company / Operating Cash Flow per Share
Oncology Institute, Inc. Operating Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.35
FY2025
5-year range
-$0.84 / $0.01
FY2021-FY2025
Trend
+28.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-0.84 to $-0.35 over the past 2 years.
Based on SEC 10-K filings.
-0.35 in FY2025.
Improved from $-0.84 to $-0.35 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 28.5% year-over-year.
- Peak operating cash flow per share was recorded in FY2021.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.35 | +28.5% |
| FY2024 | -$0.49 | +41.9% |
| FY2023 | -$0.84 | -88.9% |
| FY2022 | -$0.45 | -6533.1% |
| FY2021 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026